Search

Your search keyword '"Holland Fischer, P."' showing total 78 results

Search Constraints

Start Over You searched for: Author "Holland Fischer, P." Remove constraint Author: "Holland Fischer, P."
78 results on '"Holland Fischer, P."'

Search Results

1. Prevalence of hyperthyroidism and hypothyroidism in liver transplant recipients and associated risk factors

2. Prevalence of hyperthyroidism and hypothyroidism in liver transplant recipients and associated risk factors

4. The Danish comorbidity in liver transplant recipients study (DACOLT): a non-interventional prospective observational cohort study

5. The Danish comorbidity in liver transplant recipients study (DACOLT): a non-interventional prospective observational cohort study

6. EULAR portfolio for Rheumatology training: a EULAR School of Rheumatology initiative

7. Ankylosing spondylitis and mortality following hospitalised pneumonia: a population-based cohort study

8. Prognosis of pneumonia in patients with rheumatoid arthritis: the role of medication and disease activity prior to admission a population-based cohort study

9. Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry

15. DASIMAR: a novel prognostic biomarker for acute cirrhosis decompensation to guide early intervention - a prospective multicenter study

16. The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children

17. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

21. The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children

23. 1342 CHANGE IN SOLUBLE CD163, A MARKER OF ACTIVATED MACROPHAGES, IS ASSOCIATED WITH IMPROVEMENT IN LIVER ENZYMES AND METABOLIC PROFILE IN OBESE CHILDREN DURING LIFESTYLE INTERVENTION

29. The macrophage activation marker s CD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children.

30. Thromboembolism and bleeding in patients with atrial fibrillation and liver disease – A nationwide register-based cohort study

31. Changes in adipokines after transjugular intrahepatic porto-systemic shunt indicate an anabolic shift in metabolism.

36. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

37. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure

38. The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation.

39. Role of ammonia, inflammation, and cerebral oxygenation in brain dysfunction of acute-on-chronic liver failure patients.

40. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure.

41. Treatment of Budd-Chiari syndrome with a focus on transjugular intrahepatic portosystemic shunt.

42. Normalisation of insulin-like growth factor-I does not improve insulin action in cirrhosis.

43. Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging.

44. Effect of weight reduction on insulin sensitivity, sex hormone-binding globulin, sex hormones and gonadotrophins in obese children.

45. Insulin sensitivity and body composition in cirrhosis: changes after TIPS.

46. Soluble membrane attack complex in ascites in patients with liver cirrhosis without infections.

47. Ascites from patients with alcoholic liver cirrhosis contains higher IGF-I bioactivity than serum.

48. Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.

49. The IGF system after insertion of a transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis.

50. A 15-year-old girl with severe hemolytic Wilson's crisis recovered without transplantation after extracorporeal circulation with the Prometheus system.

Catalog

Books, media, physical & digital resources